Addition of bevacizumab enhances antitumor activity of erlotinib against non-small cell lung cancer xenografts depending on VEGF expression

Heyan Li, Koichi Takayama, Shuo Wang, Yoshimasa Shiraishi, Keisuke Gotanda, Taishi Harada, Kazuto Furuyama, Eiji Iwama, Ichiro Ieiri, Isamu Okamoto, Yoichi Nakanishi

Research output: Contribution to journalArticlepeer-review

48 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Addition of bevacizumab enhances antitumor activity of erlotinib against non-small cell lung cancer xenografts depending on VEGF expression'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds